Potential impact of sulfonylureas in the outcome of type 2 diabetic patients with ischemic stroke.
Arboix
Adrià
A
D001929:Brain Edema / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D016896:Treatment Outcome
D013453:Sulfonylurea Compounds